Arbutus Biopharma Corp (ABUS) R&D Expenses & History | Stock Alarm

Demo Sign up Log In

Arbutus Biopharma Corp · R&D Expenses

ABUS R&D Expenses

Latest reported$17.80Mperiod endingJun 30, 2026

ABUS R&D Expenses ($8.65M → $17.80M)

Annual R&D Expenses

High-resolution chart · PNG

ABUS r&d expenses history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Arbutus Biopharma Corp R&D Expenses — Annual fiscal periods (USD)
Period ending	R&D Expenses (USD)
Dec 31, 2025	25,241,000
Dec 31, 2024	54,037,000
Dec 31, 2023	73,700,000
Dec 31, 2022	84,408,000
Dec 31, 2021	65,502,000
Dec 31, 2020	49,338,000
Dec 31, 2019	57,601,000
Dec 31, 2018	57,900,000
Dec 31, 2017	62,700,000
Dec 31, 2016	61,300,000
Dec 31, 2015	51,505,000
Dec 31, 2014	38,700,000
Dec 31, 2013	21,458,258
Dec 31, 2012	18,125,426
Dec 31, 2011	0
Dec 31, 2010	22,133,983,000,000
Dec 31, 2009	0
Dec 31, 2008	0
Dec 31, 2007	8,429,988
Dec 31, 2006	4,525,636
Dec 31, 2005	8,763,227
Dec 31, 2004	22,316,491
Dec 31, 2003	23,705,879
Dec 31, 2002	21,608,641
Dec 31, 2001	12,848,984
Dec 31, 2000	8,716,006
Dec 31, 1999	7,746,310
Dec 31, 1998	8,650,736

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.